Target intelligence / Profile preview

Pattern-recognition receptors and scavenger receptors on antigen-presenting cells (PRRs and SRs on APCs)

Target
PRRs and SRs on APCs
Molecular classification
Receptor, Pattern-recognition receptor, Scavenger receptor
01

Overview

Pattern-recognition receptors (PRRs) and scavenger receptors (SRs) are diverse groups of proteins primarily expressed on antigen-presenting cells (APCs), such as dendritic cells and macrophages, where they serve as the primary sensors of the innate immune system (Kumar et al., 2011) [1]. PRRs, including Toll-like receptors (TLRs) and C-type lectin receptors (CLRs), identify conserved molecular structures known as pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Janeway & Medzhitov, 2002) [5]. Scavenger receptors facilitate the clearance of altered self-molecules, such as oxidized low-density lipoproteins, and play a critical role in phagocytosis and lipid metabolism (Zani et al., 2015) [2]. Upon ligand binding, these receptors initiate signaling pathways that lead to the maturation of APCs, the secretion of pro-inflammatory cytokines, and the subsequent activation of the adaptive immune system (Banchereau et al., 2000) [3]. In clinical practice, these receptors are targeted by agonists like Imiquimod and CpG oligonucleotides to enhance vaccine efficacy and anti-tumor immunity (Kaczanowska et al., 2013) [4]. Conversely, inhibiting these pathways is a strategy for treating chronic inflammatory conditions and autoimmune diseases where overactive innate signaling contributes to tissue damage (Zani et al., 2015) [2].

Other names
Innate immune receptorsPattern recognition moleculesPRRsScavenger receptorsSRs
02

Mechanism of action

Agonism of specific pattern-recognition receptors to stimulate innate and adaptive immunity; Antagonism of scavenger or pattern-recognition receptors to suppress pathological inflammation or lipid accumulation.

03

Biological functions

Immune responsePhagocytosisAntigen presentationInflammationPathogen recognitionHomeostasis
04

Disease associations

InfectionCancerAutoimmunityInflammationCardiovascular diseaseMetabolic disorder
05

Safety considerations

Cytokine release syndromeSystemic inflammatory responseAutoimmune reactionsOff-target immune activationTissue damage from chronic inflammation
06

Interacting drugs

Imiquimod

7 more in the full profile.

07

Biomarkers

TLR expression levelsCD36 expressionPro-inflammatory cytokine levels (TNF-alpha, IL-6, IL-12)CD80/CD86 expressionC-reactive protein (CRP)

Beyond the preview

Go deeper on Pattern-recognition receptors and scavenger receptors on antigen-presenting cells (PRRs and SRs on APCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern-recognition receptors and scavenger receptors on antigen-presenting cells (PRRs and SRs on APCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call